HomeCompareBIECX vs JNJ

BIECX vs JNJ: Dividend Comparison 2026

BIECX yields 5.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIECX wins by $9.0K in total portfolio value
10 years
BIECX
BIECX
● Live price
5.67%
Share price
$27.08
Annual div
$1.53
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$813.83
Full BIECX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BIECX vs JNJ

📍 BIECX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIECXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIECX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIECX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIECX
Annual income on $10K today (after 15% tax)
$481.80/yr
After 10yr DRIP, annual income (after tax)
$691.76/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $11.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIECX + JNJ for your $10,000?

BIECX: 50%JNJ: 50%
100% JNJ50/50100% BIECX
Portfolio after 10yr
$24.5K
Annual income
$820.81/yr
Blended yield
3.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BIECX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIECX buys
0
JNJ buys
0
No recent congressional trades found for BIECX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIECXJNJ
Forward yield5.67%3.36%
Annual dividend / share$1.53$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.1K$20.0K
Annual income after 10y$813.83$827.78
Total dividends collected$6.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BIECX vs JNJ ($10,000, DRIP)

YearBIECX PortfolioBIECX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,267$566.82$10,676$355.77+$591.00BIECX
2$12,652$596.85$11,407$389.39+$1.2KBIECX
3$14,164$626.40$12,198$426.53+$2.0KBIECX
4$15,811$655.38$13,056$467.62+$2.8KBIECX
5$17,602$683.72$13,987$513.12+$3.6KBIECX
6$19,545$711.35$14,998$563.56+$4.5KBIECX
7$21,652$738.22$16,098$619.52+$5.6KBIECX
8$23,932$764.28$17,295$681.69+$6.6KBIECX
9$26,396$789.49$18,599$750.82+$7.8KBIECX
10$29,058$813.83$20,022$827.78+$9.0KBIECX

BIECX vs JNJ: Complete Analysis 2026

BIECXStock

The fund invests primarily in equity securities of foreign companies. It typically invests in foreign companies with market capitalizations greater than $5 billion at the time of purchase. A foreign company is determined to be "foreign" on the basis of its domicile, its principal place of business, its primary stock exchange listing, and/or the source of its revenues. Under normal market conditions, the fund will invest at least 80% of its net assets measured at the time of purchase in equity securities of companies located in at least three countries outside the United States.

Full BIECX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BIECX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIECX vs SCHDBIECX vs JEPIBIECX vs OBIECX vs KOBIECX vs MAINBIECX vs ABBVBIECX vs MRKBIECX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.